5Sulkowski MS. Mast EE. Seeff LB. et al. Hepatitis C virus infection as an opportunistic disease in persons infected with human immu- nodeficiency virus[ J]. Clinical Infectious Diseases,2000,30( 1 ) : s77 - 84.
6Verucehi G ,Calza L. ,Manfredi R,et al. Human immunodeficien- cy virus and hepatitis C virus eoinfeetion: epidemiology, natural history, therapeutic options and clinical management [ J ]. Infec- tion,2004,32( 1 ) :33 -46.
7国家免费艾滋病抗病毒药物治疗手册.2版.[M].北京:人民卫生出版社,2008:89-105.
8Kottilil S, Jagannatha S, Lu A, et al. Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individuals [ J ]. HIV clinical trials ,2004,5 ( 1 ) :25 - 32.
7Ownby HE,KorelitzJJ,Busch MP,et al.Loss of volunteer blood donor because of unconfirmed enzyme immunoassay screening results.Retrovirus Epidemiology Donor Study[J].Transfusion, 1997,37:199 - 205.
8Eiras A,Sauleda S,Planelles D,et al.HCV screening in blood donations using RT-PCR in mini-pool:the experience in Spain after routine usefor 2 years[J]. Transfusion, 2003,43(6):713 - 716.
